v3.26.1
Stock Compensation Expenses (Tables)
 3 Months Ended
Mar. 31, 2026
Stock Compensation Expenses [Abstract]  
Schedule of Stock Options Activity

Stock options activity for the period ended March 31, 2026, was as follows:

 

   Number of
shares
options		   Weighted average grant date fair value per share 
         
Unvested balance as of December 31, 2025   1,691,184   $3.41 
Granted   
-
    
-
 
Vested   
-
    
-
 
Forfeited   
-
    
-
 
Unvested balance as of March 31, 2026   1,691,184   $3.41 

 

   Number of
shares
options		   Weighted average grant date fair value per share 
           
Exercisable balance as of March 31, 2026   5,886,997   $2.26 
Schedule of Restricted Stock Awards Activity

Restricted Stock Awards activity for the period ended March 31, 2026, was as follows:

 

   Number of shares RSAs   Weighted average grant date fair value per share 
         
Unvested balance as of December 31, 2025   1,054,638   $7.76 
Granted   957,797   $5.52 
Vested   191,555   $5.52 
Forfeited   175,806   $7.24 
Unvested balance as of March 31, 2026   1,645,074   $6.77 

 

    Number of shares RSAs    Weighted
average grant
date fair value
per share		 
           
Exercisable balance as of March 31, 2026   
-
    
-
 
Schedule of Common Stock Issued to Consultants as Advisory Shares

Common stock issued to consultants as advisory shares during the year as follows:

 

Grant dates  Fair value on grant date   Unvested shares in the beginning   Shares granted during the year   Shares vested during the period   Unvested shares at the end of the period 
31-Oct-23   8.99    34,541    
-
    3,454    31,087 
31-Oct-23   8.99    4,650    
-
    465    4,185 
31-Oct-23   8.99    3,700    
-
    370    3,330 
31-Oct-23   8.99    14,588    
-
    1,459    13,129 
         57,479    
      -
    5,748    51,731 
Schedule of Share Compensation Expense

During the three months period ended March 31, 2026 and March 31, 2025, the Company has recorded share compensation expense of $3,144,315 in relation to stock options, RSU and Advisory shares as follows:

 

   March 31,
2026		   March 31,
2025		 
Stock options   710,992    710,020 
Restricted stock units (RSU)   2,112,902    1,348,773 
Advisory shares   320,421    320,419 
Total stock compensation expenses   3,144,315    2,379,212 
Schedule of Weighted-Average Estimated Fair Values of Stock Options The weighted-average estimated fair values of stock options and the rights to acquire stock as well as the weighted-average assumptions used in calculating the fair values of stock options and the rights to acquire stock that were granted during the period ending March 31, 2026 were as follows:
       Period ended March 31, 2026     
Grant date  Restricted stock awards
January 09,
2026		   Stock
Options
February 13,
2024		   Stock
Options
November 27,
2023		   Restricted stock awards November 27,
2023		 
                 
Fair value on grant date  $5.52   $1.39   $3.41   $7.76 
Risk free interest rate   4.40%   4.40%   4.40%   4.40%
Expected volatility   18.29%   24.96%   18.50%   18.50%
Exercise prices  $0.0001   $5.00   $5.00   $0.0001 
Share price on the grant date  $5.52   $5.50   $7.76   $7.76 
Expected term of vesting   4 Years    2.5 years    4 years    4 years